drugset / Trial / NCT03183245
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
Phase 3
Completed
242 enrolled
Humacyte, Inc.
CTI Clinical Trial and Consulting Services · collabCalifornia Institute for Regenerative Medicine (CIRM) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access
Timeline
- Start
- 2017-09-29
- Primary completion
- 2024-04-22
- Completion
- 2025-06-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human Acellular Vessel | Other / unclassified | — | Other |